MPLT
MapLight Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.62 / 10
Netural
Liquidity flows are exceptionally strong (8.11/10), driven by positive block, medium, large, and extra-large inflows, despite a slight small-inflow deficit. Analyst consensus is overwhelmingly bullish (50% Strong Buy, 50% Buy), with historical win rates near 100%. This confluence of robust fund inflows and bullish analyst views provides a supportive backdrop, mitigating some technical and fundamental weaknesses.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-21
InstitutionJefferies
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of MPLT?
- MPLT holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.62/10 (Netural).
